Inventor

Gary John Tresadern

Inventor

Toledo, ES

Overview

2013–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 18 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%

C07DHeterocyclic compounds34%

A61KPreparations for medical, dental or toiletry purposes32%

PatentTitleYear

11,053,248[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitors2021 10,947,242[1,2,4]triazolo[1,5and#8208;A]pyrimidine compounds as PDE2 inhibitors2021 10,519,1626,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one compounds and their use as negative allosteric modulators of mGluR2 receptors2019 10,071,0951,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders2018 10,005,785Substituted 6,7-dihydropyrazolo[1,5-a] pyrazines as negative allosteric modulators of mGlUR2 receptors2018 9,840,507'5,6-dihydro-imidazo[1,2-a]pyrazin-8-ylamine derivatives useful as inhibitors of beta-secretase (BACE)'2017 9,828,3505,6-dihydro-2H-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (BACE)2017 9,737,533'1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders'2017 9,271,967'1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors'2016 9,226,930'1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders'2016 9,174,953'Bicyclic thiazoles as allosteric modulators of mGluR5 receptors'2015 9,040,707'Bicyclic thiazoles as allosteric modulators of mGluR5 receptors'2015 9,012,448'1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors'2015 8,993,591'1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors'2015 8,937,060'1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders'2015 8,785,486'Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors'2014 8,609,660'4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta-secretase (BACE)'2013 8,546,440'Substituted bicyclic imidazole derivatives as gamma secretase modulators'2013

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2013–2017Patents assigned to TRESADERN GARY JOHN (10)· patent assignee history

2013–2021Patents assigned to JANSSEN PHARMACEUTICA NV (9)· patent assignee history

2013–2018Patents assigned to JANSSEN PHARMACEUTICALS INC (9)· patent assignee history

2013–2016Patents assigned to MACDONALD GREGOR JAMES (7)· patent assignee history

2013–2021Based in Toledo, ES· patent location history

2015–2017Patents assigned to TRABANCO-SUÁREZ ANDRÉS AVELINO (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
TRESADERN GARY JOHNself	10	2013–2017
JANSSEN PHARMACEUTICA NV	9	2013–2021
JANSSEN PHARMACEUTICALS INC	9	2013–2018
MACDONALD GREGOR JAMES	7	2013–2016
TRABANCO-SUÁREZ ANDRÉS AVELINO	6	2015–2017

Locations

Location	Patents	Span
Toledo, ES	18	2013–2021